News

City of San Antonio enacting plan to better leverage military medical assets

  The San Antonio Military Life Science Commercialization Action Plan seeks to better leverage ...

Rapamycin Holdings Treats First Humans in eRapa Clinical Trial

Featured image is of SwRI staff working in their cGMP clean room where clinical supplies of their ...

Events

Learn to Prepare IND for Small Molecule Drugs

How does a drug development program evolve from a brilliant research idea? Join Southwest Research Institute ...
News
Voxelogix to be named oral surgery company of the year
March 9, 2011

By the San Antonio Business Journal

Stephen Schmitt and Ben Young of Voxelogix will accept Frost & Sullivan's North American Oral Surgery Company of the Year award on March 15. Photo: Catherine Dominguez

Market research firm Frost & Sullivan said Tuesday that Voxelogix will receive the "North American Oral Surgery Company of the Year" award during the 2011 Excellence in Medical Technologies & Life Sciences Awards Banquet in San Francisco.

Voxelogix is a San Antonio company that developed a revolutionary dental procedure called NeXsmile. The company takes a 30-second CT scan of a patient's mouth. The company then uses that data to devise a high-tech plan to replace missing or failing teeth with a custom set of teeth that are fitted with titanium implants.

"NeXsmile is designed to fulfill a huge market need for a large patient population," says Aarti Shetty, senior industry analyst of medical devices in the health care department of Frost & Sullivan. "Previously more prevalent in other fields, custom modeling and manufacturing of personalized implants is now viable for oral procedures. With NeXsmile, Voxelogix has taken the first step towards enabling that transition."

Voxelogix was incorporated in 2005 as Dental Implant Technology based on the research and development work of Stephen M. Schmitt, DDS. The company changed its named to Voxelogix in 2008.

The banquet will be held March 15.

www.voxelogix.com

 

Stay informed. Subscribe to BioMed SA news alerts.